Ali , M.M. and Mahmood, N.M.A. 2022. The Use of Cyclin-Dependent Tyrosine Kinase 4/6 (CDK4/6) Inhibitors in Breast Cancer. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 3, (Sep. 2022), 30–35. DOI:https://doi.org/10.54133/ajms.v3i.79.